Steve Davidsen
Ph.D.

Dr. Davidsen is the Founder and President of Predawn Discovery Advisors LLC and currently serves on the Scientific Advisory Boards of Nitrase Therapeutics and BioLoomics with over 35 years of experience in drug discovery and development. Previously, Dr. Davidsen served as Vice President of Oncology Discovery Research at AbbVie, where he was responsible for discovery efforts across all of AbbVie’s oncology programs and sites. He held various positions of increasing responsibility at Abbott prior to the separation of AbbVie. Dr. Davidsen has directed research teams and partnerships leading to more than 40 first-in-human clinical trials across a broad range of platforms and biology targeting both hematologic and solid tumor indications. He has more than 70 scientific publications across a diverse range of topics including metalloproteinase inhibitors, kinase inhibitors and the discovery of histone deacetylase inhibitors. Dr. Davidsen earned a Ph.D. in organic chemistry from the University of Texas at Austin and a B.S. in chemistry from the University of Maryland.